In vitro assays for determining the metastatic potential of melanoma cell lines with characterized in vivo invasiveness

被引:7
作者
Chandrasekaran, Siddarth [1 ]
Giang, Ut-Binh T. [1 ]
Xu, Lei [2 ]
DeLouise, Lisa A. [1 ,3 ]
机构
[1] Univ Rochester, Dept Biomed Engn, Rochester, NY 14611 USA
[2] Univ Rochester, Med Ctr, Dept Biomed Genet, Rochester, NY 14642 USA
[3] Univ Rochester, Med Ctr, Dept Dermatol, Rochester, NY 14642 USA
关键词
Polydimethylsiloxane; Microbubble arrays; Cell morphology; Clonogenic potential; Melanoma; Metastatic potential; TUMOR MICROENVIRONMENT; CANCER; GROWTH; MODEL; POLYDIMETHYLSILOXANE; MICROFABRICATION; CORRELATE; CAVITIES; 3D;
D O I
10.1007/s10544-016-0104-9
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
The metastatic potential of cancer cells is an elusive property that is indicative of the later stages of cancer progression. The ability to distinguish between poorly and highly metastatic cells is invaluable for understanding the basic biology of cancer and to develop more treatments. In this paper, we exploit a A375 melanoma cell line series (A375P, A375MA1, A375MA2) that vary in metastatic potential, to demonstrate an in vitro screening assay using polydimethylsiloxane (PDMS) microbubble well arrays that can distinguish these cell lines by their growth characteristics in including morphology, migratory potential, and clonogenic potential. These cell lines cannot be distinguished by their growth characteristics when cultured on standard tissue culture plastic or planar PDMS. Results show that the more metastatic cell lines (A375MA1, A375MA2) have a higher proliferative potential and a distinctive radial spreading growth pattern out of the microbubble well. The A375MA2 cell line also has a higher tendency to form multicellular spheroids. The ability to successfully correlate the metastatic potential of cancer cells with their growth characteristics is essential first step toward developing a high-throughput screening assay to identify aggressive tumor cells in primary samples. The capability to culture and recover aggressive cells from microbubble wells will enable identification of candidate metastatic biomarkers which has immense clinical significance.
引用
收藏
页数:10
相关论文
共 36 条
  • [1] Continuously perfused microbubble array for 3D tumor spheroid model
    Agastin, Sivaprakash
    Giang, Ut-Binh T.
    Geng, Yue
    DeLouise, Lisa A.
    King, Michael R.
    [J]. BIOMICROFLUIDICS, 2011, 5 (02):
  • [2] Microbubble array diffusion assay for the detection of cell secreted factors
    Bobo, Bryan
    Phelan, Dana
    Rebhahn, Jonathan
    Piepenbrink, Michael S.
    Zheng, Bo
    Mosmann, Tim R.
    Kobie, James J.
    DeLouise, Lisa A.
    [J]. LAB ON A CHIP, 2014, 14 (18) : 3640 - 3650
  • [3] Sweeping lymph node micrometastases off their feet: an engineered model to evaluate natural killer cell mediated therapeutic intervention of circulating tumor cells that disseminate to the lymph nodes
    Chandrasekaran, Siddarth
    McGuire, Matthew J.
    King, Michael R.
    [J]. LAB ON A CHIP, 2014, 14 (01) : 118 - 127
  • [4] Effect of homotypic and heterotypic interaction in 3D on the E-selectin mediated adhesive properties of breast cancer cell lines
    Chandrasekaran, Siddarth
    Geng, Yue
    DeLouise, Lisa A.
    King, Michael R.
    [J]. BIOMATERIALS, 2012, 33 (35) : 9037 - 9048
  • [5] Enriching and characterizing cancer stem cell sub-populations in the WM115 melanoma cell line
    Chandrasekaran, Siddarth
    DeLouise, Lisa A.
    [J]. BIOMATERIALS, 2011, 32 (35) : 9316 - 9327
  • [6] Microenvironment induced spheroid to sheeting transition of immortalized human keratinocytes (HaCaT) cultured in microbubbles formed in polydimethylsiloxane
    Chandrasekaran, Siddarth
    Giang, Ut-Binh T.
    King, Michael R.
    DeLouise, Lisa A.
    [J]. BIOMATERIALS, 2011, 32 (29) : 7159 - 7168
  • [7] Cutaneous malignant melanoma
    Cummins, DL
    Cummins, JM
    Pantle, H
    Silverman, MA
    Leonard, AL
    Chanmugam, A
    [J]. MAYO CLINIC PROCEEDINGS, 2006, 81 (04) : 500 - 507
  • [8] Increased incidence of second primary melanoma in patients with a previous cutaneous melanoma
    DiFronzo, LA
    Wanek, LA
    Elashoff, R
    Morton, DL
    [J]. ANNALS OF SURGICAL ONCOLOGY, 1999, 6 (07) : 705 - 711
  • [9] Doillon CJ, 2004, ANTICANCER RES, V24, P2169
  • [10] Tumor Microenvironment and Progression
    Dvorak, Harold F.
    Weaver, Valerie M.
    Tlsty, Thea D.
    Bergers, Gabriele
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2011, 103 (06) : 468 - 474